The Wilms' Tumor Gene Product (WT1) Modulates the Response to 1,25-Dihydroxyvitamin D3 by Induction of the Vitamin D Receptor

This publication has 22 references indexed in Scilit:

• 1α,25-Dihydroxyvitamin D3–Induced Myeloid Cell Differentiation Is Regulated by a Vitamin D Receptor–Phosphatidylinositol 3-Kinase Signaling Complex
  The Journal of Experimental Medicine, 1999
• Current Understanding of the Molecular Actions of Vitamin D
  Physiological Reviews, 1998
• Cloning and characterization of the mouse vitamin D receptor promoter
  Proceedings of the National Academy of Sciences, 1997
• High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome
  Blood, 1997
• Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3
  Biochemical Journal, 1996
• WT-1 is required for early kidney development
  Cell, 1993
• Alternative splicing and genomic structure of the Wilms tumor gene WT1.
  Proceedings of the National Academy of Sciences, 1991
• Transcriptional Repression Mediated by the WT1 Wilms Tumor Gene Product
  Science, 1991
• The candidate Wilms' tumour gene is involved in genitourinary development
  Nature, 1990
• Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
  Cell, 1990